Target intelligence / Profile preview

Blood-labyrinth barrier (BLB)

Target
BLB
Molecular classification
Other
01

Overview

The **blood-labyrinth barrier** (BLB) is not a molecule or receptor, but rather a unique anatomical and physiological barrier system located in the inner ear, specifically in the **stria vascularis** and other cochlear regions[1][3][7]. The BLB is formed by **endothelial cells** joined by tight junctions, **pericytes**, a **basement membrane**, and **perivascular-resident macrophage-like melanocytes**. Its core function is to **limit and regulate the exchange of solutes, metabolites, and toxins between the bloodstream and the inner ear fluids (endolymph, perilymph)**[5][6][7]. It is equivalent in concept to the blood-brain barrier, but specifically maintains the composition and homeostasis of cochlear fluids necessary for hearing[1][3]. The barrier helps protect the ear from systemic toxins and supports essential functions like nutrient supply, ion absorption, and waste excretion[6][7]. BLB dysfunction is a pathological feature in conditions such as Meniere’s disease, sensorineural hearing loss, noise- and drug-induced hearing loss, and autoimmune diseases affecting the ear[2][3][7]. There is **no single molecular target, receptor, or gene designated as "BLB"**. The BLB is considered an *anatomical barrier* and *physiological entity*, not a druggable target like an enzyme or receptor[1][2][5][7]. Recent therapeutic research aims to exploit or traverse the BLB for targeted drug delivery, for example, nanoparticle-based therapies or agents capable of modulating BLB permeability[1][6][7]. However, there are **no drugs that interact directly with "the BLB" as a target**, and it is **not classified under molecular families like receptors, enzymes, or transporters**. **Note:** - This entry is **incorrect if used as a therapeutic molecular target** or if assigned as a classic receptor, enzyme, or transporter. - If you are seeking *molecular targets* within the BLB (like tight junction proteins, transporters, or signaling molecules), further specificity is required.

Other names
Blood-labyrinthine barrierBlood-inner ear barrier
02

Biological functions

Maintenance of ionic homeostasisRegulation of solute and metabolite exchangeProtection from toxinsSelective permeabilityFluid filtration
03

Disease associations

Sensorineural hearing lossMeniere’s diseaseOtotoxicityNoise-induced hearing lossAutoimmune hearing lossAge-related hearing loss
04

Safety considerations

Barrier dysfunction may lead to elevated permeability, susceptibility to ototoxic drugs, inflammation, and hearing loss

Beyond the preview

Go deeper on Blood-labyrinth barrier (BLB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood-labyrinth barrier (BLB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call